Proteinuria in a patient using adalimumab for psoriasis.
Adam
A
Ingraffea
Anita
A
Pedvis-Leftick
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003404:Creatinine / Q000097:blood; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008297:Male; D011507:Proteinuria / Q000209:etiology* / Q000503:physiopathology; D011565:Psoriasis / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D003404:Creatinine; D000068879:Adalimumab